Tethered Capsule Imaging for Anal Lesion Detection

ClinicalTrials.gov ID: NCT07935876

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT07935876. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 14, 2026, 7:19 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Evolution of Tethered Capsule Endomicroscopy for Anal Lesion Detection

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the feasibility and tolerability of the Optical Coherence Tomography (OCT) capsule during routine High Resolution Anoscopy (HRA) at Massachusetts General Hospital (MGH).

Study identification

NCT ID: NCT07935876
Recruitment status: Enrolling by invitation
Study type: Interventional
Phase: Not applicable
Lead sponsor: Massachusetts General Hospital; Other
Enrollment: 15 participants

Conditions and interventions

Conditions

Anal Canal

Interventions

Tethered Capsule Endomicroscopy (TCE) Device

Device

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Oct 16, 2026 (Actual)
Primary completion: Dec 31, 2028 (Estimated)
Completion: Dec 31, 2029 (Estimated)
Last update posted: Nov 13, 2026

2026 – 2029

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
Massachusetts General Hospital	Boston	Massachusetts	02114	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07935876, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Nov 13, 2026 · Synced Nov 14, 2026